Cathie Wood’s ARK Investment bought 344K shares of PacBio today
EST Cathie Wood’s ARK Investment bought 344K shares of PacBio (PACB) todayMaximize Your Portfolio with Data Driven Insights:Leverage the ...
Cathie Wood’s ARK Investment bought 211K shares of Iridium today
EST Cathie Wood’s ARK Investment bought 211K shares of Iridium (IRDM) todayMaximize Your Portfolio with Data Driven Insights:Leverage the ...
Cathie Wood pares $21 million of beaten-down tech stock
Cathie Wood, head of Ark Investment Management, is known for making bold bets — but she’s not afraid to change course when ...
The Crypto Basic on MSN16h
Ark Invest CEO Says Odds of Bitcoin Reaching $1.5M Have Soared: Here’s Why
Cathie Wood, CEO and CIO of Ark Invest, has reaffirmed her bullish outlook on Bitcoin. In a recent Big Ideas 2025 ...
New study reveals how film and TV reinforce the gender investment gap
A study from King’s Business School and investment platform eToro examined several major films and television series from the last 15 years and how they have reinforced the gender investment gap, ...
7 Top-Performing Equal Weight ETFs to Buy Now
These seven equal weight ETFs offer a more balanced approach to superior performance.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood bought shares of AMD, Toast, and Shopify on Tuesday. AMD hit a new 52-week low after posting mixed quarterly ...
Finbold | Finance in Bold18h
Cathie Wood dumps Palantir stock, doubles down on these stocks
Cathie Wood and Ark Invest sold roughly $19.4 million worth of Palantir stock on February 11 and redirected funds toward ...
Crispr Therapeutics price target raised to $86 from $85 at BofA
BofA analyst Alec Stranahan raised the firm’s price target on Crispr Therapeutics (CRSP) to $86 from $85 and keeps a Buy rating on the shares. With sufficient cash to support “years of development in ...